9 tulemused
FIELD OF THE INVENTION
This invention relates in general to a modified serum albumin useful as a blood volume expander, and in particular to a recombinant or otherwise modified serum albumin that is mutated such as by truncation, elongation or insertion at its n-terminal region which has
FIELD OF THE INVENTION
This invention relates in general to a modified serum albumin useful as a blood volume expander, and in particular to a recombinant or otherwise modified serum albumin that is mutated such as by truncation, elongation or insertion at its n-terminal region which has
FIELD OF THE INVENTION
This invention relates in general to the use of a serum albumin composition as a cleansing or dermatological agent, and more specifically relates to the use of serum albumin, preferably human serum albumin produced by recombinant means, in shampoos, soaps, creams and oils for
FIELD OF THE INVENTION
The present disclosure relates to the treatment of allergic dermatitis, and in particular to allergic dermatitis resulting from contact with naturally-occurring hydrophobic toxins such as urushiol and isosolenopsin A.
BACKGROUND OF THE INVENTION
Allergic dermatitis can be
The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the
FIELD
The invention relates to fusion polypeptides. It concerns fusion polypeptides comprising an IgE-binding domain and a human serum albumin (HSA) component and salts thereof. It also concerns polynucleotides and physiologically functional equivalent polypeptides which are intermediates in the
RELATIONSHIP TO THE PRIOR ART
The concept of using conjugates of leukotrienes in a radioimmunoassay was described, by L. Levine, R. A. Morgan, R. A. Lewis, K. F. Austin, D. A. Clark, A. Marfat, and E. J. Corey, Proceeding of the National Academy of Sciences, U.S.A., Vol. 78, No. 12 7692 (1981) This
RELATIONSHIP TO THE PRIOR ART
The concept of using conjugates of leukotrienes in a radioimmunoassay was described, by L. Levine, R. A. Morgan, R. A. Lewis, K. F. Austin, D. A. Clark, A. Marfat, and E. J. Corey, Proceeding of the National Academy of Sciences, U.S.A., Vol. 78, No. 12 7692 (1981). This
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel water soluble extract from nonpathogenic aerobic corynebacteria. More particularly, the invention relates to a water soluble extract from nonpathogenic aerobic bacteria, the said extract having the following